Leukemia study looking at LEF1 protein levels
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study is examining levels of a protein called LEF1 in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Researchers want to see if LEF1 can help predict survival and confirm diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with CLL or SLL, a type of blood cancer.
- You were an adult when diagnosed.
- You have a stored tissue sample (from a lymph node, other organ, or bone marrow) that was already tested for LEF1 protein.
- You have already had genetic or chromosome tests done on that sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced tests (genetics and other 'omics' methods) to better understand your leukemia and find a treatment that targets its specific features. It may help if standard treatments haven't worked or stopped working.
This study uses advanced 3D lab models to test personalized treatments for certain types of blood cancer (CLL, SMZL, HCL). It aims to find better ways to use immunotherapy and combination therapies for each patient.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study looks at a genetic change called SF3B1 mutation in people with acute or chronic lymphocytic leukemia. It aims to understand how this mutation affects the disease and may help guide treatment decisions.
This study follows people newly diagnosed with chronic lymphocytic leukemia (CLL), a type of blood cancer, to learn more about the disease and how it progresses. By participating, you help researchers understand CLL better, which may improve future treatments.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
Hear when a new Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.